Banner
Study: Caloric Restriction In Humans And Aging

In mice, caloric restriction has been found to increase aging but obviously mice are not little...

Science Podcast Or Perish?

When we created the Science 2.0 movement, it quickly caught cultural fire. Blogging became the...

Type 2 Diabetes Medication Tirzepatide May Help Obese Type 1 Diabetics Also

Tirzepatide facilitates weight loss in obese people with type 2 diabetes and therefore improves...

Life May Be Found In Sea Spray Of Moons Orbiting Saturn Or Jupiter Next Year

Life may be detected in a single ice grain containing one bacterial cell or portions of a cell...

User picture.
News StaffRSS Feed of this column.

News Releases From All Over The World, Right To You... Read More »

Blogroll

Omega-3 fatty acids protect the brain against Parkinson’s disease, according to a study by Université Laval researchers published in the online edition of the FASEB Journal, the journal of the Federation of American Societies for Experimental Biology. This study, supervised by Frederic Calon and Francesca Cicchetti, is the first to demonstrate the protective effect of a diet rich in omega-3 fatty acids against Parkinson’s.

Parkinson’s disease is caused by the progressive death of the neurons responsible for producing dopamine, a neurotransmitter closely linked with movement control. The disease is usually diagnosed when 50 to 80% of these neurons are already dead, and there is currently no medication to stop that process.

ROCHESTER, Minn. -- A review of 62 Mayo Clinic patients who underwent cryoablation to treat cancerous kidney tumors shows that the patients are cancer free for up to two and a half years after having had the procedure.

Also called cryotherapy or cryosurgery, cryoablation is a procedure in which extreme cold is applied to the tumor using a cryoprobe, a hollow needle-like device filled with argon gas. The gas rapidly freezes the targeted tumor.

As this study and others continue to show, cryoablation appears to be an effective treatment for cancerous kidney tumors.

Call for adequate initial system to produce insights, forecasts useful to public, policy makers

Speedy diagnosis of the temper and vital signs of the oceans matters increasingly to the well being of humanity, says a distinguished partnership of international scientists urging support to complete a world marine monitoring system within 10 years.

The Partnership for Observation of the Global Oceans (POGO) says warming seas, over-fishing and pollution are among profound concerns that must be better measured to help society respond in a well-informed, timely and cost-effective way.

“A system for ocean observing and forecasting that covers the world’s oceans and their major uses can reduce growing risks, protect human interests and monitor the health of our precious oceans,” say

A variant of the gene CDC2 could possibly be used as a risk marker for Alzheimer’s disease. The gene variant is considerably more common among Alzheimer’s patients. This is shown in a dissertation from the Sahlgrenska Academy at Göteborg University in Sweden.

Alzheimer’s disease has several different causes. Since many patients have a close relative who also developed the disease, heredity is believed to be one of the most important factors.

“There is a previously identified Alzheimer’s gene that indicates an elevated risk of developing the disease, but we want to find more genes with a strong connection to Alzheimer’s.

Scientists from the Helmholtz Centre for Infection Research (HZI) have discovered a class of natural substances that are produced by soil bacteria and prevent somatic cells from dividing. After years of in-depth research, the US pharmaceuticals company Bristol-Myers Squibb is now launching this agent on the American market as a treatment for cancer.

The epothilones that Prof. Gerhard Höfle and Prof. Hans Reichenbach of the HZI have been studying for more than 20 years are produced by myxobacteria living in the soil. Epothilones block the somatic cell components known as microtubules, preventing the cells from dividing any further and causing them to die off and decompose.

Chemists from the University of Delaware, in collaboration with a colleague at the University of Wisconsin, have set a new world record for the shortest chemical bond ever recorded between two metals, in this case, two atoms of chromium.

The distance? A minuscule 1.803 Angstroms, which is on the order of a billionth of the thickness of a human hair.

The chemists weren't driven by the Guinness Book of World Records or even a friendly bet. As is often the case in science, they discovered the molecule, which has a quintuple (i.e., fivefold) bond, quite by accident.


Klaus Theopold, professor and chairperson of the University of Delaware Department of Chemistry and Biochemistry. Photo: Kathy F.